Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals, Inc.

Date Founded



480 arsenal street, watertown, MA, 02472, USA

Type of Company


Employees (Worldwide)



Hospitals & Patient Services

Company Description

Tetraphase Pharmaceuticals, Inc. engages in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also engages in the development of product candidate, eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Watertown, MA.

Contact Data
Trying to get in touch with decision makers at Tetraphase Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees


Accounts Payable Coordinator

Director, Chemical Development

Project Manager

Accounting Manager

Operations Manager

Research Scientist II, Analytical Chemistry

Media Relations Contact

Board of Directors

Former Vice President, Finance, Chief Financial Officer & Secretary at Horizon Pharmaceutical LLC

Founder at Tang Capital Management LLC

Paths to Tetraphase Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
Tetraphase Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

La Jolla Pharmaceutical Co. purchases Tetraphase Pharmaceuticals, Inc.

Details Hidden

Tetraphase Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Tetraphase Pharmaceuticals, Inc. issued USD Common Stock

Transaction Advisors
Escrow Agent

Advised onTetraphase Pharmaceuticals, Inc. issued USD Common Stock


Advised onTetraphase Pharmaceuticals, Inc. issued USD Common Stock


Advised onTetraphase Pharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onTetraphase Pharmaceuticals, Inc. issued USD Common Stock

Managing Director

Advised onTetraphase Pharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onTetraphase Pharmaceuticals, Inc. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Partner at Wilmer Cutler Pickering Hale and Dorr LLP


Former Chief Scientific Officer & Executive Vice President at Idenix Pharmaceuticals LLC


Managing Director at Argot Partners LLC


Boston University (most commonly referred to as BU) is a private research university located in Boston, Massachusetts. The university is nonsectarian, but is historically affiliated with the United Methodist Church. The university has more than 4,000 faculty members and 29,000 students,and is one of Boston's largest employers. It offers bachelor's degrees, master's degrees, and doctoral degrees, and medical and dental degrees through 18 schools and colleges on two urban campuses. The main campus is situated along the Charles River in Boston's Fenway-Kenmore and Allston neighborhoods, while the Boston University Medical Campus is in Boston's South End neighborhood. BU also operates 75 study abroad programs in over 33 cities in over 20 countries and has internship opportunities in 10 different countries (including the United States and abroad).

CUBRC, Inc. is an independent non-profit research and development company. It offers research, development, testing, and systems integration programs in information exploitation, medical biotechnology, chemical and biological defence, public health and safety, hypersonic, and professional services. The company was founded in 1983 and is headquartered in Buffalo, NY.

Everest Medicines Ltd. operates as a biopharmaceutical company which focuses on licensing, clinical development and commercialization of globally therapies to address critical unmet medical needs in Greater China and other emerging Asia Pacific markets. The company was founded in 2017 and is headquartered in Shanghai, China.

Key Stats and Financials As of
Market Capitalization
Total Enterprise Value
Earnings Per Share
Details Hidden

Limulus Management Co LLC invests in healthcare/life science companies located in the US. The firm focuses on companies with intellectual property positions and growth potential. It targets companies operating in the fields of biopharmaceutical technology and life sciences information. It provides financing for early stage capital requirements with an investment size ranging from $4 to $8 million.

Details Hidden

Skyline Ventures invests in outstanding companies in all sectors of the healthcare market, including biotechnology, therapeutics, medical devices, consumables and equipment for life sciences research and healthcare information technology. Most often, they lead or co-lead a company's first institutional venture round, but occasionally have helped found or co-found a company, participated in a LBO or invested in a PIPE transaction. Initial investments range from $7 million to $10 million with a total of $15 million to $35 million over the life of the company. They tend to focus on the San Francisco area but have also invested in Boston, San Diego, Denver, the Midwest and Florida

Details Hidden

Flagship Pioneering seeks investment opportunities in companies located globally. The firm focuses on companies operating in the fields of therapeutics, life science tools & diagnostics, and bioenergy or cleantech. It provides financing for seed, early, and later-stage capital requirements. It acts as a lead investor. It also makes co-investments.

Harvard University Schools & Student Services | Cambridge, MA

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Thermo Fisher Scientific, Inc. Computer Software | Waltham, Massachusetts

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Novasep Holding SAS Chemicals | Lyon, France

Novasep Holding SAS provides manufacturing solutions for the life science industries. Its products include agrochemicals fine chemicals and food ingredients. The company was founded by Roger-Marc Nicoud in 1995 and is headquartered in Lyon, France.

Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Melinta Therapeutics, Inc. Pharmaceuticals - New Haven, CT

Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Tetraphase Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Tetraphase Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Tetraphase Pharmaceuticals, Inc..